| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800097 | 重组HER2人源化单克隆抗体单甲基奥瑞他汀F偶联剂注射液 | LCB14-0110 | Injection | Biological Products(1) | New Drug Application | 2018-10-09 | 上海复星医药产业发展有限公司 | Shanghai Fosun Pharmaceutical Industrial Development Co Ltd | In Review | 2018-10-08 | view |